This study examined effects of bone bonding and nonbonding implants on parameters associated with matrix vesicle-mediated primary bone formation, matrix vesicle alkaline phosphatase and phospholipase A2 specific activities, and phosphatidylserine content. Tibia marrow ablation followed by implantation of KG-Cera, Mina 13 (bonding), KGy-213, or M 8/1 (nonbonding) was used as the experimental model. Postsurgery, matrix vesicle-enriched microsomes (MVEM) were isolated from implanted and contralateral limbs. MVEM alkaline phosphatase and phospholipase A2 were stimulated adjacent to bonding implants with similar, though reduced, effects contralaterally. Alkaline phosphatase exhibited slight stimulation in nonbonding tissue; phospholipase A2 was inhibited or unchanged in treated and contralateral limbs. Phosphatidylserine content of MVEM was differentially affected by the implant materials. Thus, MVEM are modulated by implant materials locally and systemically. The data demonstrate that the model is a biologically relevant diagnostic for assessing the tissue/implant interface, primary calcification is affected by implant materials, and implant-specific effects are detected in the contralateral unimplanted limb.
The early responses of host and hydroxyapatite/l~-tricalciumphosphate (HA-TCP) porous ceramic implants were studied using light microscopy (LM), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) at 3, 7, 14, 21, and 28 days after implantation into the femur of rats. Micropores ( < 5 t~m) and macropores of the implant surface provided effective structures for anchoring of various tissue components. Mineralization started directly on the implant surface and was observed in macropores and micropores, suggesting bone-bonding by epitaxis. Bone-bonding was observed with and without an amorphous intervening interface layer. The composition of this layer and the mechanisms guiding its production are not yet fully understood. Extracellular matrix filled up the clefts between HA-TCP crystal grain clusters. These processes contributed to the mechanical stabilization of the interface. Slight changes of implant grain surface morphology were observed which were explained by leaching of impurities, such as TCP and/or by dissolution acting on single grains. Diameters of pores and HA-TCP grains did not change in a period up to 28 days, which seems to be related to the relatively short periods of insertion and the material properties. Leaching and degradation were observed and loose particles of implant origin were phagocytosed by macrophages and multinuclear giant cells which dominated at non-bonding interfaces.
A new composite implant material titanium/glass-ceramic was tested in rabbits using light microscopy, histomorphometry, and biomechanical testing methods. Two rabbit implant models were used. The first premolar tooth was replaced and cylinders inserted into the trabecular bone of the distal femur below the patella sliding plane. There was bone bonding to the glass-ceramic component and additional mechanical interlocking, due to bone ingrowth between the titanium matrix into secondary pores. This was proved by measuring the tensile strength at the interface of the new composite material which was in the same range as compared to pure glass-ceramic implants. In tooth replacement there was a tight attachment of gingival epithelium and stroma to composite titanium/glass-ceramic. These results are of particular clinical interest: physicochemical bone bonding and additional mechanical interlocking result in a resistance of the implant material against shear and tensile loads at the interface. Therefore this new composite material should be suitable for further load-bearing applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.